Related Experiment Video
Updated: May 5, 2026

A Preclinical Model to Assess Brain Recovery After Acute Stroke in Rats
Published on: November 6, 2019
D-Arginine as a neuroprotective amino acid: promising outcomes for neurological diseases
1National University of Northeast, School of Medicine, Department of Biophysics, Corrientes 3400, Argentina.
Abstract:
In humans, as in other mammals, endogenous glucocorticoids (GCs) are essential for adapting to physiological life stress. They are also crucial for the healthy development of the fetus. However, when the physiological concentrations of GCs increase over a long period of time, the central nervous system (CNS) is predisposed to the development of psychiatric disorders and neurological diseases. Here, I discuss the strong influence of GCs on the nitric oxide (NO) pathway and the generation of reactive oxygen species (ROS). I also highlight supporting evidence for the neuroprotective actions of d-arginine (d-Arg) against neurotoxicity induced by high levels of GCs in the CNS. Given that d-Arg does not interfere with the immunosuppressive and anti-inflammatory effects of GCs, this might be a novel way of neutralizing the neurotoxic effects of GCs in the CNS without compromising their positive peripheral actions.
More Related Videos
08:44Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
Published on: September 1, 2016
10:13Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia
Published on: July 31, 2017
Related Concept Videos
The Blood-brain Barrier
Alzheimer's Disease: Treatment